Background: SCN1A is the most clinically relevant epilepsy gene, most mutations causing Dravet syndrome (also known as severe myoclonic epilepsy of infancy or SMEI). We evaluated clinical differences, if any, between young patients with and without a SCN1A mutations and a definite clinical diagnosis of Dravet syndrome.
Early clinical features in Dravet syndrome patients with and without SCN1A mutations / Petrelli C; Passamonti C; Cesaroni E; Mei D; Guerrini R; Zamponi N; Provinciali L.. - In: EPILEPSY RESEARCH. - ISSN 0920-1211. - STAMPA. - 99 (1-2):(2012), pp. 21-27. [10.1016/j.eplepsyres.2011.10.010]
Early clinical features in Dravet syndrome patients with and without SCN1A mutations.
GUERRINI, RENZO;
2012
Abstract
Background: SCN1A is the most clinically relevant epilepsy gene, most mutations causing Dravet syndrome (also known as severe myoclonic epilepsy of infancy or SMEI). We evaluated clinical differences, if any, between young patients with and without a SCN1A mutations and a definite clinical diagnosis of Dravet syndrome.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.